Gene · 3914
Papers1,750
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,750
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epidermolysis Bullosa-A Kindler Syndrome Case Report and Short Literature Review. | Clin Pract | 2023 | 37623260 | PubTator, text mining | PubMed |
| Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis. | Nat Commun | 2023 | 37612267 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response. | Nat Commun | 2023 | 37596273 | PubTator, text mining | PubMed |
| The circadian clock protein Cryptochrome 1 is a direct target and feedback regulator of the Hippo pathway. | iScience | 2023 | 37593458 | PubTator, text mining | PubMed |
| Integrated multi-omics analyses reveal Jorunnamycin A as a novel suppressor for muscle-invasive bladder cancer by targeting FASN and TOP1. | J Transl Med | 2023 | 37587470 | PubTator, text mining | PubMed |
| Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer. | Front Mol Biosci | 2023 | 37577750 | PubTator, text mining | PubMed |
| The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients. | Int J Mol Sci | 2023 | 37569414 | PubTator, text mining | PubMed |
| The Impact of CC16 on Pulmonary Epithelial-Driven Host Responses during Mycoplasma pneumoniae Infection in Mouse Tracheal Epithelial Cells. | Cells | 2023 | 37566063 | PubTator, text mining | PubMed |
| Extravillous trophoblast cell lineage development is associated with active remodeling of the chromatin landscape. | Nat Commun | 2023 | 37563143 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma. | Oncol Res | 2023 | 37547764 | PubTator, text mining | PubMed |
| Unraveling the Relevance of Tissue-Specific Decellularized Extracellular Matrix Hydrogels for Vocal Fold Regenerative Biomaterials: A Comprehensive Proteomic and In Vitro Study. | Adv Nanobiomed Res | 2023 | 37547672 | PubTator, text mining | PubMed |
| Evaluation of Clinical and Oral Findings in Patients with Epidermolysis bullosa. | Medicina (Kaunas) | 2023 | 37511997 | PubTator, text mining | PubMed |
| Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity. | Int J Mol Sci | 2023 | 37511126 | PubTator, text mining | PubMed |
| Machine-learning and combined analysis of single-cell and bulk-RNA sequencing identified a DC gene signature to predict prognosis and immunotherapy response for patients with lung adenocarcinoma. | J Cancer Res Clin Oncol | 2023 | 37507593 | PubTator, text mining | PubMed |
| Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers. | Cancer Res Commun | 2023 | 37476073 | PubTator, text mining | PubMed |
| Predicting the immune microenvironment and prognosis with a anoikis - related signature in breast cancer. | Front Oncol | 2023 | 37469408 | PubTator, text mining | PubMed |
| Identifying a Lung Stem Cell Subpopulation by Combining Single-Cell Morphometrics, Organoid Culture, and Transcriptomics. | Stem Cells | 2023 | 37468433 | PubTator, text mining | PubMed |
| Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers. | Explor Target Antitumor Ther | 2023 | 37455825 | PubTator, text mining | PubMed |
| Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology. | Cancers (Basel) | 2023 | 37444576 | PubTator, text mining | PubMed |
| End-stage kidney disease: a never healing wound leading to another never healing wound, renal cancer. | J Nephrol | 2023 | 37439962 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3914/papers?page=9